Latest News and Updates

Stay informed about conveyxo’s progress in RNA-enhanced exosome, partnerships, scientific advancements, and company milestones.
‍
Explore our latest announcements, collaborations, and insights as we continue developing next-generation regenerative therapeutics.

October 2, 2025
Conveyxo has been selected for the prestigious Saudi Biotechnology Accelerator‘s Venture Readiness Program 2025!
October 1, 2025
New collaboration! conveyxo is teaming up with SATT Paris-Saclay to load their miRNA cargo into our exosomes and evaluate therapeutic impact against intestinal inflammation (IBD)
September 12, 2025
Was a honor to pitch at Beiersdorf Connect – invitation-only – alongside 4 other inspiring founders and a sharp jury!
September 1, 2025
We are thrilled to welcome Alexandre Lennaertz to the conveyxo team as our Operations Manager
August 16, 2025
Charles Jacques is appointed as Chief Finance Officer
April 28, 2025
convEyXO is thrilled to welcome Tamara Davenne, PhD, to the management team as Translational Science Leader
July 15, 2024
BIO Informant – EXO-Harvest, an affiliate of convEyXO, is thrilled to announce the successful launch of its cutting-edge multi-scale bioreactor platform for adherent cells and extracellular vesicles (EVs) production, in partnership with IPRATECH.
July 10, 2024
EXO-Harvest, an affiliate of convEyXO, is thrilled to announce the successful launch of its cutting-edge multi-scale bioreactor platform for adherent cells and extracellular vesicles (EVs) production, in partnership with IPRATECH.
June 26, 2023
convEyXO’s affiliate EXO-HARVEST collaborates with IPRATECH
May 26, 2023
convEyXO et SomesTech annoncent la création de la joint-venture XomeXBio pour développer le potentiel des exosomes ciblés en tant que système de délivrance de médicaments en médecine personnalisée
May 26, 2023
Conveyxo and SomesTech Announce XomeXBio Joint Venture to Unleash Full Potential of Targeted Exosomes as drug delivery system for precision medicine